Written question asked by Tanmanjeet Singh Dhesi (Labour) on Monday, 24 May 2021, in the House of Commons. It was due for an answer on Wednesday, 26 May 2021. It was answered by Jo Churchill (Conservative) on Thursday, 17 June 2021 on behalf of the Department of Health and Social Care.
Mucormycosis
- Question
-
To ask the Secretary of State for Health and Social Care, what assessment he has made of the risk of covid-19 patients in the UK developing mucormycosis.
- Answer
-
There has been a very low incidence of mucormycosis secondary to COVID-19 infections in the United Kingdom. Across 2020 and 2021, there have been 66 incidences of invasive fungal infection, of which only four incidences have been associated with COVID-19.
Secondary information
- Type
- Written question
- Reference
- 6428
- Session
- 2021-22
- Subjects
- Patients Coronavirus Mucormycosis
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-06-17 13:36:16 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/6428
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/6428
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/6428